Lilly Buys AtaiBeckley, Wonder Raises $650M, AI Decodes the Brain

July 17, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

• Eli Lilly acquires AtaiBeckley for up to $3.8B, the largest psychedelic medicine deal yet, gaining an intranasal DMT therapy in Phase 3 for depression
• Wonder closes $650M Series D at $9B valuation, building a vertically integrated food platform spanning restaurants, delivery, and AI personalization
• Hemispheric emerges from stealth with $52M and Descartes, a foundation AI model trained on EEG data to diagnose depression, PTSD, and Alzheimer's

Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more.

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider

Reach out → [email protected]